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Background: Cell display technologies (e.g. bacterial display) are attractive in directed evolution as they provide
the option to use flow-cytometric cell sorting for selection from combinatorial libraries. The aim of this study was to
engineer and investigate an expression vector system with dual functionalities: i) recombinant display of Affibody
libraries on Escherichia coli for directed evolution and ii) small scale secreted production of candidate affinity proteins,
allowing initial downstream characterizations prior to subcloning. Autotransporters form a class of surface proteins in
Gram-negative bacteria that have potential for efficient translocation and tethering of recombinant passenger proteins
to the outer membrane. We engineered a bacterial display vector based on the E. coli AIDA-I autotransporter for
anchoring to the bacterial surface. Potential advantages of employing autotransporters combined with E. coli as host
include: high surface expression level, high transformation frequency, alternative promoter systems available, efficient
translocation to the outer membrane and tolerance for large multi-domain passenger proteins.
Results: The new vector was designed to comprise an expression cassette encoding for an Affibody molecule, three
albumin binding domains for monitoring of surface expression levels, an Outer membrane Protease T (OmpT) recognition
site for potential protease-mediated secretion of displayed affinity proteins and a histidine-tag for purification. A panel of
vectors with different promoters were generated and evaluated, and suitable cultivation conditions were investigated.
The results demonstrated a high surface expression level of the different evaluated Affibody molecules, high correlation
between target binding and surface expression level, high signal-to-background ratio, efficient secretion and purification
of binders in OmpT-positive hosts as well as tight regulation of surface expression for the titratable promoters. Importantly,
a mock selection using FACS from a 1:100,000 background yielded around 20,000-fold enrichment in a single round and
high viability of the isolated bacteria after sorting.
Conclusions: The new expression vectors are promising for combinatorial engineering of Affibody molecules and the
strategy for small-scale production of soluble recombinant proteins has the potential to increase throughput of the entire
discovery process.
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Protein engineering using combinatorial libraries is a
well-established approach for selection of specific affinity
proteins (e.g. recombinant antibody fragments). Selec-
tions from such libraries are commonly performed using
various display technologies (e.g. phage display), creating
a physical link between phenotype and genotype [1]. Cell
surface display technologies (e.g. yeast and bacterial dis-
play) have several properties that are suitable for library
applications, such as the convenience of using self-
amplifying living cells [2]. The large particle size com-
bined with a multivalent display format is particularly
important since it allows for single cells to be sorted
using fluorescence-activated cell sorting (FACS), enab-
ling real-time visualization of the selection process, and
quantitative isolation of high-affinity binders [3]. This is
not possible using for example phage or ribosome display.
We have previously developed a Gram-positive bacterial
display technology based on expression of recombinant
proteins on the surface of Staphylococcus carnosus [4,5].
The selection system has been successfully employed for
generation of high-affinity single domain antibodies [6]
and other alternative affinity proteins, including Affibody
molecules [4,7-9]. Affibody molecules are based on a small
three-helical domain (58 aa) with advantageous properties
such as high thermal stability, rapid and reversible folding,
high solubility, no cysteines, flexible pharmacokinetics and
high tolerance for multiple mutations [10-12]. In a num-
ber of previous studies, a wide array of specific Affibody
molecules with high affinity for various antigens has been
selected using phage display, Gram-positive bacterial dis-
play and ribosome display [4,7,13]. A common challenge
with all microbial-displayed combinatorial libraries is to
reach a sufficiently high number of transformants during
library construction. Gram-negative bacteria, such as
Escherichia coli, are typically demonstrating higher trans-
formation frequencies than for example yeast or Gram-
positive bacteria and have the same potential as phage
display for creation of really large libraries [14-16].
E. coli also has a rapid growth rate [17] and is the most
well-characterized host for expression of recombinant
proteins and is hence attractive for library applications.
In this study, we therefore sought to design and evaluate
an E. coli display method for Affibody libraries to com-
plement the existing toolbox of technologies for engin-
eering of new Affibody molecules.
Several formats for display of recombinant proteins and
peptides on E. coli have been described previously [18-26].
However, although E. coli has several valuable properties,
one of the major challenges is to enable the recombinant
protein of interest to successfully cross two membranes
and tether to the outer membrane [27]. In Gram-negative
bacteria, a natural solution for secreting proteins to the cell
surface is the autotransporter system [28]. The secretedprotein consists of an N-terminal signal peptide followed
by the passenger protein and a C-terminal β-domain. The
signal peptide mediates transport of the unfolded protein
sequence through the inner membrane to the periplasm
using the sec apparatus [29]. Transit through the periplasm
and secretion through the outer membrane is a complex
process, involving several chaperones [30-32]. Briefly, the
β-domain is inserted into the outer membrane where it
forms a β-barrel pore structure, through which the passen-
ger protein is transported to the cell surface [30-32]. In
addition to the efficient transport mechanism of passenger
proteins through both membranes, autotransporters are at-
tractive alternatives for surface display of recombinant pro-
teins because of their reported high surface expression
levels [33]. A high surface expression has potential to
yield a large signal-to-background ratio in the flow cyt-
ometer, and consequently a more efficient sorting of
positive variants. Various autotransporters have been
used for the display of different recombinant proteins,
including disulphide-containing proteins [32,34].
In this study, we used the autotransporter Adhesin
Involved in Diffuse Adherence (AIDA-I), which is a natural
plasmid-encoded autotransporter of some enteropatho-
genic E. coli strains [35-37]. Importantly, AIDA-I has pre-
viously been successfully used for display of several
different recombinant passenger proteins, which was en-
couraging for our efforts [33]. Earlier studies include for
example work on toxins [22], enzymes, [38-41], and small
libraries for engineering of enzyme inhibitors [33,42]. The
Z domain from staphylococcal protein A has also been
successfully used as a model passenger protein of AIDA-I
in a study on optimization of bioreactor cultivation condi-
tions [43], as well as for signal amplification in an immu-
noaffinity biosensor assay [44]. However, these methods
were not intended and not evaluated for combinatorial
protein engineering by FACS, and lacked for example
strategies for normalization of the surface expression level.
The first example of a modified autotransporter in com-
binatorial protein engineering of new affinity proteins was
reported by Skerra and coworkers, describing the work on
sortings from an anticalin library that was displayed using
the autotransporter EspP [23]. More recently, another
group displayed a nanobody library in fusion to the auto-
transporter EhaA and selected binders using magnetic
beads [24]. The previous work demonstrates the potential
for autotransporters in library applications. However, we
are not aware of any reported use of AIDA-I for combina-
torial protein engineering of affinity proteins.
In this study, an expression vector for display on
E. coli was designed and engineered to comprise a sub-
cloning site for Affibody molecules in fusion to the
AIDA-I autotransporter. The expression cassette also in-
cluded a surface expression reporter tag for normalization
of target binding signal against expression levels during
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ent parameters for expression to find suitable culturing
conditions for the constructs. The most promising vector
was used for surface display of a panel of Affibody mo-
lecules with diverse specificities and FACS-mediated
selection from a mock library efficiently enriched target-
binding bacteria from a non-binding background. Further-
more, a straightforward strategy for small-scale protein
production of soluble candidates using the same expres-
sion vector was explored. In summary, we have designed
and evaluated new expression vector systems for Affibody
molecules, which are intended for both display of com-
binatorial libraries as well as small-scale production of sol-
uble proteins. We believe the expression systems have
potential to further advance the discovery process of fu-
ture Affibody reagents.
Results and discussion
Design and construction of dual-purpose expression vector
In order to investigate the use of AIDA-I for display of
Affibody molecules on the surface of E. coli, an expres-
sion vector was designed based on the pMK90 vector
[45], encoding the aidA autotransporter gene (except the
native passenger) under control of the constitutive aidA
promoter [36] (Figure 1A). The expression vector encoded
for a signal peptide from AIDA-I for translocation of the
recombinant protein through the inner membrane, and
the AIDA-I C-terminal β-domain for translocation of the
recombinant protein through the outer membrane and
display on the bacterial surface (Figure 1A). An IgG-
specific Affibody molecule (ZIgG) was inserted between
the signal peptide and the β-domain as model Affibody
molecule for the study. An albumin binding protein (ABP)
was fused on the C-terminal side of the Affibody and
intended to function as a reporter tag for monitoring of
the surface expression level of individual bacteria. It has
previously been shown that normalization of target binding
against surface expression level during FACS dramatically
increases the ability to discriminate binders of different af-
finities [46]. ABP contains three albumin-binding domains
derived from streptococcal protein G [47], and would
hence serve as a long spacer that would minimize potential
steric hindrance between the Affibody molecule and the
target protein from the bulky cell surface (Figure 1A). As
illustrated in Figure 1B-C, the expression vector was also
engineered to potentially enable small-scale secretion-
based production of selected affinity protein candidates
after selection. An OmpT protease site was therefore intro-
duced between the Affibody and the ABP, intended for
protease-mediated release of the affinity protein into the
medium during cultivation in an OmpT-positive E. coli
strain (Figure 1A-C). A His6-tag was also introduced to fa-
cilitate purification of the secreted product (Figure 1A-C).
The dual-purpose expression vector was transformed toOmpT-negative E. coli BL21(DE3) and the functionality
of the IgG-specific Affibody molecule as well as the
ABP was investigated using flow-cytometric analysis.
The functionality of the displayed ZIgG was confirmed
by the binding of biotinylated IgG (monitored by the
binding of phycoerythrin-conjugated streptavidin to the
biotinylated IgG, represented on the Y axis of the dot
plot in Figure 2A). The IgG binding signal was normal-
ized against the surface expression level by monitoring
of the binding of Alexa Fluor 647-HSA conjugate to the
ABP in the displayed construct (represented on the X
axis in Figure 2A). The results demonstrated that the
recombinant bacteria were indeed able to simultan-
eously bind fluorescently labeled IgG and HSA, indicat-
ing that both ZIgG and ABP were functionally displayed
on the E. coli outer membrane and the normalization
strategy worked as intended (Figure 2A).
Construction of expression vectors with inducible
promoters
The natural AIDA-I promoter (aidA) is a constitutive
promoter (Additional file 1: Table S1), which might re-
sult in problems with growth bias in future selections
from bacterial-displayed libraries, as has been reported
for other E. coli display technologies [48,49]. The expres-
sion cassette was therefore subcloned to three alternative
vectors, containing inducible promoters (T7, araBAD
and rhaBAD), and the new expression vectors were eval-
uated using flow cytometry (Figure 2B). The T7 pro-
moter in combination with the BL21(DE3) strain is a
well-established and strong promoter for overexpression
of recombinant proteins, but is practically non-titratable
(Additional file 1: Table S1) [50]. The araBAD and
rhaBAD promoters are in contrast titratable promoters,
enabling relatively precise control over the protein ex-
pression levels [51,52] (Additional file 1: Table S1). In
general, high levels of displayed recombinant proteins
are desirable for achieving a high fluorescent signal in
the flow cytometer, but overexpression of recombinant
membrane proteins might also cause issues with toxicity
[48-50]. The surface expression level, monitored by the
binding of HSA to ABP, and the binding of IgG to ZIgG,
were analyzed by flow cytometry. Although bacteria with
the T7 promoter were expressing recombinant protein
on the surface, the vector was not further evaluated due
to issues with low cell viability, substantially decreased
growth rate and occasional loss of surface expression
(data not shown). Similar problems have previously been
reported with recombinant overexpression of membrane
proteins and are likely due to saturation of the secretion
pathway and connected toxicity [49,50]. The expression
vectors containing the araBAD and the rhaBAD pro-
moters demonstrated no toxicity-related issues and were
therefore used in the further investigations (Figure 2C).
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Figure 1 Schematic illustration of the expression cassette, including the recombinant protein to be displayed on E. coli as well as the
optional process for selection from displayed libraries or secreted production. A. The expression cassette (EC) contains a promoter region,
a signal peptide for translocation over the inner membrane, an Affibody molecule as binding protein, a His-tag for purification, an OmpT cleavage
site for secretion, a surface expression reporter-tag for normalization and the AIDA-C for insertion into the outer membrane. AIDA-I numbering is
according to the UniProt accession number Q03155 (http://www.uniprot.org). B. The recombinant fusion protein expressed in two different strains
of E. coli. In an OmpT negative strain the recombinant protein remains tethered in the outer membrane and thus displayed on the bacterial
surface, allowing for phenotype-genotype linkage and FACS. In an OmpT positive strain, OmpT will cleave the recombinant protein and release
the Affibody molecule fused to a His-tag into the medium. C. Schematic drawing of a potential workflow using E. coli display for selecting
Affibody molecules from libraries using FACS. After selection of new Affibody variants, the expression vector is transformed into an OmpT
positive strain that results in protease-mediated secretion of candidates for downstream characterization.
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dramatically lower fluorescent signals, indicating that the
observed fluorescence from the induced samples originatedfrom specific interactions between recombinant Affibody
molecules and fluorescently labeled target proteins on the
bacterial surface (Additional file 2: Figure S1A).









































































Figure 2 Different inducible promoters compared to the constitutive aidA promoter for surface expression of recombinant protein.
A. Representative dot plot from flow-cytometric analysis of E. coli BL21 (paidA-ZIgG-EC). Fluorescence intensity corresponding to IgG-binding on
the y-axis and fluorescence intensity corresponding to surface expression level (HSA-binding) on the x-axis. B. The different inducible promoters
AraBAD, RhaBAD and T7 before the expression cassette (EC). C. Representative dot plot from flow-cytometric analysis of E. coli BL21
(pRhaBAD-ZIgG-EC). D. Representative dot plot from flow-cytometric analysis of E. coli BL21 (pAraBAD-ZIgG-EC).
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Next, we explored the range of suitable cultivation con-
ditions using the two vectors that resulted in appropriate
surface expression of the recombinant Affibody mole-
cules. Induction time and temperature were evaluated by
flow-cytometric analysis after induction in LB medium
for 1 h, 3 h, 6 h and 16 h, at 25°C, 30°C and 37°C, re-
spectively (Additional file 3: Figure S2A). The effect of
inductor concentration was evaluated using different
concentrations of L-arabinose and L-rhamnose (0.01%,
0.1%, 0.2%, 0.4%, 0.6%, 0.8% and 1.0%) (Additional file 3:
Figure S2B). The screening revealed that both vectors
should be induced for at least 3 hours for sufficient sur-
face expression and no dramatic differences in expres-
sion were observed between 25°C, 30°C and 37°C. Still,
induction at higher temperatures yielded in general a
somewhat increased surface expression level (Additional
file 3: Figure S2A). It should also be noted that the higher
expression at 37°C for arabinose-induced cultures resulted
in more non-expressing bacteria, which is an indication of
overexpression-induced toxicity (Additional file 3: Figure
S2A). The evaluation of various inductor concentrations
demonstrated that 0.1% of either arabinose or rhamnosewas sufficient for surface display of Affibody molecules
(Additional file 3: Figure S2B). Under these conditions, the
cell population was relatively uniform and well separated
from the background, and the non-expressing population
was in general small (Additional file 3: Figure S2). A clear
correlation between IgG-binding fluorescence intensity
and surface expression level was also observed, suggesting
that the distribution in target-binding signal was mainly
the result from variation in surface expression level among
different cells (Additional file 3: Figure S2). It should be
noted that the rhaBAD promoter requires addition of glu-
cose to the medium for tight regulation, which might
complicate extended assays that have a potential risk of
glucose depletion [52]. Hence, to minimize such problems
in future sortings of bacterial libraries, we used the ara-
BAD promoter in the evaluations of the technology for
isolation of bacterial clones with FACS.
Estimation of display level
An estimation of the number of displayed recombinant
proteins per cell was performed by a direct comparison
to staphylococcal cells displaying ZIgG on the surface [4].
The display level of recombinant staphylococci has
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cell [53]. Comparison of the ZIgG-displaying E. coli to
the staphylococci using flow cytometry revealed a higher
mean fluorescence intensity for the recombinant E. coli,
indicating that the display level was >10,000 copies per
cell on average (Additional file 2: Figure S1B).
Enzymatic detection of surface display
In order to confirm the display of the recombinant pro-
tein on the E. coli surface using a non-flow cytometric
approach, an enzymatic assay was performed. Cells dis-
playing ZIgG were labeled with biotinylated IgG, followed
by HRP-conjugated streptavidin. The IgG binding was
detected by addition of substrate, and the absorbance
was measured at 370 nM. Non-induced cells as well as
cells labeled with only secondary reagents were included
as negative controls. Almost a 4-fold higher binding sig-
nal was observed for the IgG-displaying E. coli cells
compared to the negative controls, hence supporting the
results from the flow-cytometric analysis (Additional
file 4: Figure S3).
Display of Affibody molecules with different target
specificities
The flow-cytometric analysis demonstrated that the IgG-
specific Affibody molecule was well expressed on the
E. coli surface and retained its binding capacity to IgG.
To verify that other Affibody molecules with diverse
specificities and sequences also could be functionally
displayed on the bacteria, the genes encoding three un-
related Affibody molecules (targeting TNF-α, HER3 and
HER2, respectively) were subcloned into the expression
vector and transformed to E. coli BL21 (DE3). Bacteria
expressing the three different Affibody molecules were
analyzed by flow cytometry and the assay demonstrated
that all three were displayed at a high level on the sur-
face and recognized their respective targets (Figure 3A).
The results thus suggested that the display system was
suitable for display of Affibody molecules with different
target specificities, which was encouraging for future
library applications.
Investigation of enrichment factor by FACS
Flow-cytometric sorting was thereafter performed in
order to investigate the ability to enrich target-binding
bacteria from a large non-binding background popula-
tion. Bacteria displaying ZIgG on the surface were mixed
at a ratio of 1:100,000 with cells displaying the HER2-
specific Affibody molecule (ZHER2). For enrichment of
ZIgG-displaying cells, one round of flow-cytometric cell
sorting was performed using labeled IgG (Figure 3B).
Sorted cells were collected and amplified by cell growth
over night followed by determination of the enrichment
using flow cytometry. The analysis demonstrated thatthe binding population in the upper right quadrant had
increased to approximately 21 ± 11%, corresponding to
an enrichment factor of around 20,000-fold in one cycle
(Figure 3B).
Investigation of cell viability after flow-cytometric
cell sorting
Multiple sorting rounds are usually required for enrich-
ment of high-affinity binders from large libraries and the
possibility to amplify isolated clones by cell growth in
between the cycles greatly facilitates the engineering
process. However, high-speed cell sorting subjects the
particles in the flow to relatively high shear stress, which
might influence the viability of the bacteria. The degree
of viability of the bacterial cells was hence investigated
by high-speed sorting of recombinant E. coli directly
onto plates with semi-solid medium, containing selective
antibiotics. After overnight incubation, the number of
formed colonies was counted and the results revealed
that around 90% (87 ± 9%) of sorted bacteria were viable
after FACS and able to grow into colonies (Figure 3C
and Additional file 2: Figure S1C). Together with the
high enrichment factor, the results from the viability
assay suggested that the E. coli display technology has a
high potential for future engineering of new Affibody
molecules by FACS.
Evaluation of OmpT-mediated release and small-scale
purification of displayed recombinant proteins
Production and purification of soluble protein is neces-
sary for downstream characterization of candidates se-
lected from microbial-displayed libraries, and usually
requires subcloning to a new expression vector. To po-
tentially circumvent this step and improve the through-
put of the entire protein engineering process, we
included a His6-tag and an OmpT site for release of the
affinity protein into the medium upon expression in
OmpT positive strains (Figure 1). The His6-tag was in-
cluded to enable straightforward purification of the re-
leased affinity protein from the medium using IMAC.
The efficiency of OmpT digestion for release of dis-
played protein into the medium was evaluated by trans-
formation of the display vector into the OmpT positive
strain E. coli DH5α (Invitrogen). Flow-cytometric ana-
lysis showed a dramatic reduction in target-binding sig-
nal in OmpT-positive bacteria, indicating that the ZIgG
had been proteolytically processed and released into the
medium (Figure 4A). The surface expression level signal
(monitored by the binding of fluorescently labeled HSA
to ABP) was also somewhat reduced, potentially due to
unspecific OmpT cleavage. The supernatant was purified
using IMAC and SDS-PAGE revealed one band corre-
sponding to the theoretical size and no detectable con-
taminants (Figure 4B). No bands were observed from
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Figure 3 Surface expression of different Affibody molecules on E. coli and fluorescence-activated cell sorting from spiked library.
A. Representative dot plots from flow-cytometric analysis of E. coli BL21 (pAraBAD-ZHER2-EC), (pAraBAD-ZHER3-EC) and (pAraBAD-ZTNFα-EC),
respectively. Fluorescence intensity corresponding to target-binding on the y-axis and fluorescence intensity corresponding to surface expression
level (HSA-binding) on the x-axis. B. Representative dot plots from flow-cytometric sorting of a 1:100,000 mix of E. coli BL21 (pAraBAD-ZIgG-EC) in a
background of E. coli BL21 (pAraBAD-ZHER2-EC). Leftmost dot plot shows the mixed population before FACS with the sorting gate indicated in the
dot plot. Rightmost dot plot shows the enriched bacteria after sorting and overnight growth. The percentage (mean ± standard deviation) of
events in the upper right (UR) quadrant is indicated in the dot plots. The entire experiment was performed in duplicates on different days, using
freshly prepared mixtures of bacteria expressing ZHER2 and ZIgG, and freshly prepared reagents. C. Viability test after FACS. Bacterial colonies after
sorting 100 (10 x 10 pattern) single bacterial cells directly on a plate containing semi-solid medium with antibiotics and overnight incubation at
37°C. The viability assay was performed in triplicates on different days.
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controls, indicating that the purified protein corresponded
to the recombinant Affibody molecule and that it was se-
creted by OmpT-mediated proteolysis (Figure 4B). The
purified protein was analyzed by ESI-LC/MS, confirming
that the product had the expected molecular weight, indi-
cating a specific proteolytic release (Figure 4C). The con-
centration was estimated using UV spectrophotometry
and the yield was calculated to around 3 ± 0.5 mg/l shakeflask cell culture, which is usually sufficient for initial
downstream characterization of selected Affibody candi-
dates prior to subcloning for large scale production of the
most promising variants. Moreover, the binding of ZIgG to
IgG was analyzed in a biosensor assay to verify that the
function of the protein was not affected by the proteolytic
digestion and purification strategy. IgG was immobilized
on the chip surface and purified ZIgG was injected at dif-































































Surface Expression Level 
HSA (log FI)





































Figure 4 Evaluation of OmpT-mediated release and small-scale purification of displayed Affibody molecule. A. Flow-cytometric analysis
for comparison of surface expression of recombinant proteins between pAraBAD-ZIgG-EC in OmpT-negative E. coli BL21 and pAraBAD-ZIgG-EC in
OmpT-positive E. coli DH5α. B. SDS-PAGE showing IMAC-purified supernatants from pAraBAD-ZIgG-EC in OmpT-negative E. coli BL21 and pAraBAD-ZIgG-EC
in OmpT-positive E. coli DH5α. Supernatants from non-induced samples, indicated with (−), were included as controls. C. Mass spectrum from ESI-MS
analysis of IMAC-purified supernatants from pAraBAD-ZIgG-EC in OmpT-positive E. coli DH5α. Theoretical molecular weight of the OmpT-cleaved ZIgG-His6 is
9712 Da. D. SPR-based biosensor analysis on the IMAC-purified ZIgG-His6. Response units (RU) on the y-axis and time on the x-axis. Representative
sensorgrams from injection of ZIgG-His6 at three different concentrations over human IgG immobilized on the chip surface. Injections were performed
in duplicates.
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binding capacity of the proteolytically released Affibody
molecule, indicating that the described secretion approach
might be valuable in the future for rapid production of se-
lected candidates after FACS without the need for subclon-
ing (Figure 4D). The successful OmpT-mediated release of
functional ZIgG also confirmed the display of the recombin-
ant proteins on the bacterial surface.
Conclusions
We have investigated the AIDA-I autotransporter for
display of Affibody molecules on E. coli and demon-
strated efficient FACS-mediated enrichment of bacteria
expressing target-binding Affibody molecules from a non-
binding background population. Moreover, we showed
that the same expression vector could be used for efficient
small-scale production of soluble proteins, which were se-
creted into the medium. Secretion was achieved by inser-
tion of an OmpT recognition site into the construct,
resulting in proteolytic release of recombinant protein
from the cell surface in OmpT-positive strains. Thesecretion was investigated using flow cytometry, IMAC,
SDS-PAGE and mass spectrometry and the results dem-
onstrated that the strategy yielded pure soluble proteins of
correct size and retained binding functionality at a yield of
around 3 mg purified protein per liter cell culture. Al-
though secretion of recombinant proteins to the medium
is typically more complicated in Gram-negative bacteria
compared to other hosts [54], it has been demonstrated in
previous studies [22,55]. For example, Sevastsyanovich
and co-workers used a serine protease autotransporter
from Enterobacteriaceae for successful secretion of vari-
ous proteins [55]. The mechanism for secretion in their
system was based on intramolecular cleavage of the trans-
located protein and therefore required no additional pro-
tease [55]. However, although it might be more efficient
for soluble secretion, it requires mutation of the cleavage
site for achieving surface display. In contrast, the approach
used in our study allowed for either display on the outer
membrane or secretion of soluble product into the super-
natant by simply switching host strain. Maurer and co-
workers used OmpT for release of recombinant passenger
Fleetwood et al. Microbial Cell Factories  (2014) 13:179 Page 9 of 13protein into the supernatant [22]. However, unlike the sys-
tem presented in this study, their method was not
intended for combinatorial protein engineering and small-
scale protein production for downstream characterization
of selected variants. In combinatorial protein engineering
applications, it has potential to increase the throughput of
future selections and downstream characterizations of
Affibody molecules. A reduction in surface expression
level of ABP observed in the flow-cytometric analysis indi-
cated that unspecific cleavage of OmpT might occur.
However, this did not affect the purity or size of the
cleaved ZIgG detected by SDS-PAGE and mass spectrom-
etry. The site for unspecific cleavage could potentially be
mapped and mutated in order to avoid any problems for
future applications.
Four different promoters were evaluated in the study
and the results showed that the titratable rhamnose and
arabinose promoters were highly suitable for recombin-
ant expression of Affibody molecules on E. coli. Flow-
cytometric analysis showed a high surface expression
level and high correlation between target binding and
surface expression level, suggesting that ABP is appro-
priate as normalization tag in this system. In total,
the recombinant fusion protein comprised four inde-
pendently folded domains (i.e. one Affibody and three
albumin-binding domains) as well as a His-tag and an
OmpT-site, confirming that the AIDA-I autotransporter
is efficient for translocation and tethering of relatively
large and multidomain proteins. The analysis also re-
vealed a high signal-to-background ratio, which is
promising for future sorting of libraries. Indeed, we ob-
served around 20,000-fold enrichment after one cycle
when sorting target-binding bacteria from a 1:100,000
background. In combinatorial protein engineering, high
cell viability after sorting is important in order to avoid
time-consuming re-transformation steps or extended
sortings to reach sufficient oversampling. We sorted the
recombinant E. coli directly onto semi-solid medium
and the viability assay revealed that around 90% of
sorted cells could form colonies. The high viability indi-
cated that the integrity of the outer cell membrane was
not severely affected by the display of our recombinant
protein construct. The viability was higher than re-
ported in other similar studies [23] and might poten-
tially be the result of the non-toxic surface expression
levels that are achievable using the titratable promoters.
Skerra and coworkers have previously evaluated AIDA-I
along with a few other autotransporters for display of
anticalines, demonstrating more promising results for
the EspP [23]. In this study, we showed that AIDA-I can
be used for efficient display of Affibody molecules under
the control of a tightly regulated and titratable pro-
moter. We found that the cultivation conditions and the
choice of promoter had an impact on display level andcell viability. For example, the use of the aidA promoter
resulted in a considerably higher degree of non-
displaying cells compared to inducible promoters, and
the T7 promoter had a severe negative impact on the
cell viability. The results also indicate that many differ-
ent types of autotransporters will probably be suitable
for recombinant display, but each might require an in-
dependent optimization of cultivation conditions.
In summary, we have demonstrated that the engineered
expression vectors are efficient for surface display of various
Affibody molecules on E. coli as well as for secreted pro-
duction of soluble recombinant proteins. In combination
with the high transformation frequency of E. coli, the
AIDA-I-based system has potential to be a powerful future
complement to existing methods (e.g. phage and staphylo-
coccal display) for generation of new Affibody molecules.
Methods
Bacterial strains
Escherichia coli strain RR1ΔM15 [56] and E. coli strain
DH5α (Invitrogen, Carlsbad, CA) were used for subclon-
ing work. E. coli strain BL21 (DE3) (Merck, Darmstadt,
Germany) was used for cell surface display. E. coli DH5α
(Invitrogen) was used for OmpT-mediated release of re-
combinant protein into the medium.
Construction of expression vectors
DNA fragments encoding ZIgG, His6, OmpT cleavage site
and ABP were subcloned into the vector pMK90 [45],
containing parts of the aidA gene under control of the
aidA promoter [36]. The native passenger has been de-
leted from pMK90, and the AIDA-I sequence comprises:
the natural AIDA-I signal peptide (49 aa), a linker region
(78 aa), and the entire β-barrel domain (440 aa) [45].
The ZIgG-His6 DNA fragment was amplified by PCR
using Phusion polymerase (Finnzymes, Espoo, Finland).
The reverse primer was designed to contain an OmpT
cleavage site on the C-terminal side of the ZIgG se-
quence, and a mutation of a lysine in position 49 to glu-
tamine in order to delete a potential OmpT cleavage site
in ZIgG. The pMK90 plasmid and the PCR-amplified
ZIgG-His6-OmpT fragment were digested with XmaI and
XbaI (New England Biolabs, Beverly, MA, USA). The
plasmid and PCR fragment were ligated using a T4 DNA
ligase (New England Biolabs), and transformed to E. coli
DH5α cells (Invitrogen) by heat shock. Plasmids were
prepared using a QIAprep minispin kit (Qiagen, GmbH,
Hilden, Germany). Sequences were confirmed by sequen-
cing using BigDye thermo cycle sequencing reactions (Ap-
plied Biosystems, Foster City, CA) and a DNA sequencer
ABI Prism® 3730 Analyzer (Applied Biosystems).
The gene encoding the albumin-binding protein (ABP;
three albumin-binding domains from streptococcal pro-
tein G) was amplified by PCR from pSCZ1 [4] using
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The PCR fragment and the pMK90ZIgGHisOmpT vector
were digested with XbaI (New England Biolabs). The
vector was first dephosphorylated using Antarctic Phos-
phatase (New England Biolabs) and purified by phenol
chloroform extraction. The dephosphorylated and puri-
fied vector and the ABP fragment were ligated using T4
DNA ligase (New England Biolabs). The ligated vector
was transformed into E. coli DH5α electrocompetent cells
(Invitrogen), and plasmids were prepared using a QIAprep
minispin plasmid preparation kit (Qiagen). Two potential
OmpT protease cleavage sites in the ABP sequence were
mutated (K51Q and K126Q) using QuikChange multi mu-
tation kit (Stratagene, Heidelberg, Germany) according to
the supplier’s recommendations.
The expression cassette, containing sequences encod-
ing AIDA-I, ZIgG, His6, OmpT site and ABP, was ampli-
fied by PCR using the pMK90-ZIgG-His6-OmpT-ABP as
template, and was subcloned into the plasmids pET-26b
(+) (Merck, Darmstadt, Germany), pBAD33 [51] and
pRHA67K (Xbrane Bioscience, Stockholm, Sweden).
Correct clones were transformed to E. coli BL21 (DE3)
(Merck), or DH5α (Invitrogen) using heat shock. The new
expression vectors were denoted pAraBAD-Z-EC, pRha-
BAD-Z-EC, paidA-Z-EC and pT7-Z-EC, respectively.
Cultivation of recombinant E. coli
Colonies of E. coli BL21 (DE3) (Merck) containing the dis-
play vectors were inoculated to Luria Bertani (LB) medium
containing appropriate antibiotics and grown for 16 hours
at 37°C and 150 rpm. An aliquot of the culture was diluted
1:100 and cultivated at 37°C and 150 rpm until absorbance
at 600 nm (A600) reached 0.5. Recombinant protein ex-
pression was induced by addition of appropriate inductor
(0.6% L-arabinose for all experiments carried out after the
evaluation of cultivation conditions), or no inductor for
non-induced negative controls, and grown at 25–37°C for
3 – 16 hours.
Flow-cytometric analysis
An aliquot of approximately 108 recombinant bacteria was
added to 1×PBSP (phosphate-buffered saline (PBS) with
0.1% Pluronic F108 NF surfactant (BASF Corporation,
Mount Olive, NJ)), pelleted by centrifugation (15000 g,
6 min, 4°C), re-suspended in 22 nM biotinylated human
polyclonal IgG, and incubated at room temperature with
gentle mixing for 45 min. Cells were then washed with ice-
cold 1xPBSP, re-suspended in 10 μg/ml streptavidin conju-
gated with R-Phycoerythrin (Invitrogen) and 150 nM Alexa
Fluor 647-Human Serum Albumin (HSA) conjugate, and
incubated on ice for 30 min. The samples were then
washed with ice-cold 1×PBSP, resuspended in 1×PBSP, and
analyzed using a Gallios™ flow cytometer (Beckman
Coulter, Inc., Indianapolis, IN, USA).Investigation of cultivation conditions
E. coli BL21 (DE3) (Merck) cells containing the pAra-
BAD-Z-EC and pRhaBAD-Z-EC vectors, respectively,
were cultivated as described above. Induction temperature
and induction time were investigated by induction for 1 h,
3 h, 6 h or 16 h at 37°C, 30°C or 25°C, respectively. For
each sample, a non-induced control was included. Differ-
ent concentrations of L-arabinose and L-rhamnose were
investigated by induction using various concentrations
(0.01%, 0.1%, 0.2%, 0.4%, 0.6%, 0.8% and 1.0%). Surface
expression level and target binding was analyzed for all
samples by flow cytometry as described above and the ex-
periments were performed in duplicates on different days
using freshly prepared samples and reagents.
Estimation of display level
For estimation of the display level, recombinant S. carnosus
cells displaying ZIgG were cultivated as previously described
[4], and labeled for flow cytometry in parallel to E. coli cells
displaying ZIgG under the control of the AraBAD promoter,
induced with 0.6% L-arabinose overnight at 25°C.
Enzymatic detection of surface display
E. coli BL21 (DE3) (Merck) cells containing the pAra-
BAD-Z-EC vector were cultivated as described above,
and induced with 0.6% L-arabinose at 25°C overnight. A
non-induced sample was included as a negative control.
Cells were labeled with biotinylated IgG as described for
the flow-cytometric analysis, followed by streptavidin-HRP
(Dako, Glostrup, Denmark) as a secondary reagent. Detec-
tion of IgG binding was performed by resuspending the
cells in 3,3′, 5,5′ Tetramethylbenzidine (TMB) substrate
(Sigma), and the absorbance was measured at 370 nm using
a Fluostar Omega plate reader (BMG Labtech, Germany).
The experiment was performed in triplicates.
Display of Affibody molecules with different target
specificities
DNA fragments encoding the Affibody molecules: ZHER3
(Z05416, [7]), ZHER2 (Z0342, [57]) and ZTNFα (ZTNFα-1 [4])
were amplified by PCR, and digested with NheI and
XmaI restriction enzymes (New England Biolabs). The
digested fragments were ligated into the pAraBAD-Z-
EC, digested with the same enzymes using T4 DNA lig-
ase (New England Biolabs), and transformed into E. coli
RR1ΔM15 [56]. Plasmids were prepared using a Jetstar
Plasmid Maxiprep Kit (Genomed, Bad Oeynhausen,
Germany) and transformed into E. coli BL21 (DE3)
(Merck). Flow-cytometric analysis was performed as
described above, but using biotinylated HER3 (R&D
Systems), HER2 (R&D Systems), and TNFα (R&D Sys-
tems), respectively. The experiment was performed in
duplicates on different days using freshly prepared
samples and reagents.
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Recombinant E. coli BL21 (DE3) (pAraBAD-ZIgG-EC)
displaying ZIgG (cultured and induced as above) were
mixed at a ratio of 1:100 000 with E. coli BL21 (DE3)
(pAraBAD-ZHER2-EC) displaying the Affibody molecule
ZHER2. Labeling of approximately 10
8 cells with IgG for
flow cytometry was performed as described above. One
round of sorting was performed using a MoFlo Astrios
flow cytometer (Beckman Coulter). Sorted cells were
collected in an eppendorf tube containing LB medium,
and incubated at 37°C for 1 h before inoculation to LB
supplemented with 0.05 mg/ml chloramphenicol and
cultivation overnight, followed by induction and labeling
for flow-cytometric analysis. The experiment was per-
formed in duplicates on different days using freshly pre-
pared samples and reagents. In addition, 100 cells were
sorted using a MoFlo Astrios flow cytometer (Beckman
Coulter) using typical library sorting settings directly
onto a TBAB plate containing 0.02 mg/ml chloram-
phenicol, and incubated at 37°C overnight.Evaluation of OmpT-mediated release of ZIgG into
the medium
The expression vector pAraBAD-ZIgG-EC was trans-
formed into OmpT positive E. coli DH5α (Invitrogen)
using electroporation. OmpT negative E. coli BL21(DE3)
containing pAraBAD-ZIgG-EC as well as non-induced
cultures of both strains were included as controls in the
experiment. Bacteria were cultivated and induced as de-
scribed above. Cells were pelleted by centrifugation at
16000 g, 4°C for 10 min. The supernatant was filtered
(0.45 μm) followed by immobilized metal ion affinity
chromatography (IMAC) using PD-10 columns (GE
Healthcare, Uppsala, Sweden) containing 6 ml of HisPur™
Cobalt Resin (ThermoScientific, Rockford, USA). After
loading the supernatant, the column was washed with
18 ml wash buffer (15 mM imidazole, 50 mM Na(P)
300 mM NaCl), followed by elution using PBS containing
0.5 M imidazole. The imidazole was removed using PD-10
desalting columns (GE Healthcare) Protein concentration
was estimated using UV-spectrophotometry for calcula-
tion of yield. The experiment was performed in duplicates
on different days using freshly prepared samples and re-
agents. The eluate was analyzed by SDS-PAGE (BioRad,
Berkley, CA, USA) and ESI-LC/MS using an Agilent 6520
ESI-Q-TOF LC/MS instrument (Agilent Technologies,
Santa Clara, CA, USA). The binding of purified ZIgG to
IgG was analyzed in an SPR-based biosensor assay using a
Biacore 3000 instrument (GE Healthcare). Human IgG
was immobilized by amine coupling on a CM5 chip (GE
Healthcare, Uppsala, Sweden), and 1 nM, 2.5 nM and 5
nM purified ZIgG was injected for 200 s, and allowed to
dissociate for 1800 s.Additional files
Additional file 1: Table S1. Properties of the evaluated promoters and
vectors. Table listing properties of the evaluated expression vectors,
including: original vector backbone, promoter, inductor compound, size
(bp), selection marker and copy number.
Additional file 2: Figure S1. A. Comparison of induced and non-induced
E. coli cells containing the display vectors pAraBAD-ZIgG-EC and pRhaBAD-ZIgG-
EC. Histograms show the IgG-binding signal. C. Viability test after FACS.
Bacterial colonies after sorting 100 (10 x 10 pattern) single bacterial cells
directly on a plate containing semi-solid medium with antibiotics and
overnight incubation at 37°C. B. Estimation of expression level. Histograms
showing the IgG-binding signal obtained from flow-cytometric analysis of
staphylococcal cells (containing the staphylococcal display vector pSCZIgG)
as well as E. coli cells containing the display vector pAraBAD-ZIgG-EC.
Additional file 3: Figure S2. Evaluation of different induction
conditions. A. Representative dot plots from flow-cytometric analysis of
different induction conditions for E. coli BL21 (pAraBAD-ZIgG-EC) and
(pRhaBAD-ZIgG-EC), respectively. Induction temperature and induction
time were investigated by induction for 1 h, 3 h, 6 h or 16 h at 37°C, 30°C or
25°C, respectively (indicated above the dot plots). B. Representative dot plots
from flow-cytometric analysis of different inductor concentrations for E. coli
BL21 (pAraBAD-ZIgG-EC) and (pRhaBAD-ZIgG-EC), respectively. Different
concentrations of L-arabinose and L-rhamnose were investigated by
induction using various concentrations: 0.01%, 0.1%, 0.2%, 0.4%, 0.6%, 0.8%
and 1.0% (indicated above the dot plots). Fluorescence intensity
corresponding to target-binding on the y-axis and fluorescence intensity
corresponding to surface expression level (HSA-binding) on the x-axis.
Additional file 4: Figure S3. Enzymatic detection of surface display.
Histograms showing the IgG-binding signal obtained from ZIgG-displaying
bacteria labeled with biotinylated IgG and HRP-conjugated streptavidin.
The binding signal for each sample is presented as the absorbance at
370 nm normalized against the absorbance of cells labeled with only
secondary reagents. A sample with non-induced bacteria was included as
negative control. The experiment was performed in triplicates.
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